Skip to main content
Year archive

SUPHA PHARMACHEM LIMITED — 2022 filings

All 39 regulatory filings released by SUPHA PHARMACHEM LIMITED (539561) in 2022, sourced directly from the official regulator.

39 Filings
2022 Period
2022 filings (39)
Filing Released Lang
Intimation of closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations. 2015
Regulatory Filings
2022-12-28 English
This is to inform you that after considering the recommendation and report of the Audit Committee and the Committee of Independent Directors, the Board of Directors of Remedium Lifecare ....
Regulatory Filings
2022-12-17 English
With reference to the captioned subject, we hereby intimate you that after considering the recommendation and report of the Audit Committee and the Committee of Independent Directors, the ....
Regulatory Filings
2022-12-16 English
The Board of Directors of the Company at their meeting held on 14.11.2022 have approved the Memorandum of Understanding ('MOU') for the proposed merger of MVK Lifesciences Private Limited ....
Regulatory Filings
2022-11-15 English
Submission of Newspaper clippings for publication of Unaudited Financial Results for the quarter and half year ended September 30, 2022.
Regulatory Filings
2022-11-07 English
Unaudited Financial Results For The Quarter and Half Year Ended 30.09.2022
Regulatory Filings
2022-11-04 English
Unaudited Financial Results For The Quarter Half Year Ended 30.09.2022
Regulatory Filings
2022-11-04 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2022-10-18 English
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2022
Regulatory Filings
2022-10-12 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2022
Regulatory Filings
2022-10-12 English
Intimation of Closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2022-09-28 English
Scrutinizer Report and E-Voting Result for the 33rd Annual General Meeting held on 20.09.2022
Regulatory Filings
2022-09-21 English
Outcome of 33rd Annual General Meeting held on 20.09.2022
Regulatory Filings
2022-09-20 English
Annual Report for the F.Y. 2021-22.
Regulatory Filings
2022-08-27 English
Newspaper Advertisement for 33rd Annual General Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-27 English
Newspaper Advertisement for 33rd Annual General Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-27 English
33rd Annual General Meeting (AGM) of the Company will be held on Tuesday, 20th September, 2022 at 10.00 am through VC/OAVM. Book Closure: From Wednesday 14th September, 2022 to Tuesday ....
Regulatory Filings
2022-08-26 English
33rd Annual General Meeting (AGM) of the Company will be held on Tuesday, 20th September, 2022 at 10.00 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Regulatory Filings
2022-08-26 English
Announcement under Regulation 30 (LODR)-Newspaper Publication
Regulatory Filings
2022-08-16 English
Unaudited Financial Results for the quarter ended 30.06.2022
Regulatory Filings
2022-08-12 English
Outcome of Board Meeting held on 12.08.2022
Regulatory Filings
2022-08-12 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2022-08-03 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 2022.
Regulatory Filings
2022-07-08 English
Intimation of Closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2022-06-30 English
Announcement under Regulation 30 (LODR)-Newspaper Publication
Regulatory Filings
2022-06-01 English
Results - Audited Financial Results for the quarter and year ended March 31, 2022
Regulatory Filings
2022-05-30 English
Outcome of the Board Meeting held on 30.05.2022
Regulatory Filings
2022-05-30 English
Annual Secretarial Compliance Report for the year ended 31.03.2022
Regulatory Filings
2022-05-27 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings
2022-05-23 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-05-12 English
Compliances - Certificate under Regulation 40(9)of SEBI (LODR) Regulations, 2015 for the year 2021-22.
Regulatory Filings
2022-04-29 English
Compliance Certificate under Regulation 7(3) of the SEBI (LODR) Regulations 2015 for the year ended 31.03.2022
Regulatory Filings
2022-04-11 English
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2022.
Regulatory Filings
2022-04-08 English
Intimation of closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2022-03-31 English
Submission of Newspaper Publication of quarterly results for quarter ended 31st December,2021
Regulatory Filings
2022-02-11 English
Results- Financial Results for the quarter ended 31.12.2021
Regulatory Filings
2022-02-09 English
Outcome of the Board Meeting held on 09.02.2022
Regulatory Filings
2022-02-09 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve Board Meeting Intimation ....
Regulatory Filings
2022-02-02 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021.
Regulatory Filings
2022-01-13 English